Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

BACKGROUND: Malignant pleural mesothelioma is almost always fatal, and few treatment options are available. Although active symptom control (ASC) has been recommended for the management of this disease, no consensus exists for the role of chemotherapy. We investigated whether the addition of chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Muers, Martin F, Stephens, Richard J, Fisher, Patricia, Darlison, Liz, Higgs, Christopher MB, Lowry, Erica, Nicholson, Andrew G, O'Brien, Mary, Peake, Michael, Rudd, Robin, Snee, Michael, Steele, Jeremy, Girling, David J, Nankivell, Matthew, Pugh, Cheryl, Parmar, Mahesh KB
Formato: Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2431123/
https://www.ncbi.nlm.nih.gov/pubmed/18486741
http://dx.doi.org/10.1016/S0140-6736(08)60727-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2431123/
https://www.ncbi.nlm.nih.gov/pubmed/18486741
http://dx.doi.org/10.1016/S0140-6736(08)60727-8

Ejemplares similares